How to evaluate a compounding pharmacy before you fill a prescription
A short checklist turns "does this pharmacy seem trustworthy" into a check you can run yourself.
TL;DR
- A trustworthy compounding pharmacy is licensed in your state, third-party tested, and has a clean FDA record.
- PCAB (Pharmacy Compounding Accreditation Board) accreditation helps, but it isn't required.
- Skipping these checks means you can't verify what's actually in your prescription.
What it means to evaluate a compounding pharmacy
Evaluating a compounding pharmacy means confirming who oversees it before you trust it with a prescription. We've covered PCAB accreditation and section 503A's history elsewhere. Compounding falls under two FDA (U.S. Food and Drug Administration) categories. Section 503A pharmacies compound patient-specific prescriptions. Section 503B outsourcing facilities register with the FDA and are inspected under CGMP (current good manufacturing practice — plain English: strict manufacturing rules).
How to evaluate a compounding pharmacy: the checklist
How to evaluate a compounding pharmacy comes down to six checks. Confirm state licensure through the NABP (National Association of Boards of Pharmacy) directory. A pharmacy needs a license in your state, not just its own. Confirm 503A or 503B status, and note PCAB accreditation, if present. Ask if finished preparations, not just ingredients, are potency- and sterility-tested, and whether a COA (certificate of analysis) is available. Confirm USP <797> compliance for sterile preparations, or USP <795> for non-sterile ones. Then search FDA warning-letter records for its name.
Who asks about compounding pharmacy evaluation
People ask how to evaluate a compounding pharmacy after a prescriber recommends a compounded medication and they want to confirm the source is legitimate. Others ask after reading a pharmacy's FDA warning letter. The real question is rarely whether compounding is legal — it almost always is — but how to check this specific pharmacy.
What FDA inspection and warning-letter records show
The FDA's Inspection Classification Database is public and searchable by pharmacy name, with inspections classified No Action Indicated, Voluntary Action Indicated, or Official Action Indicated (FDA, 2026). A review of FDA warning letters from 2017-2022 found repeated sterility and potency citations tied to weak quality controls (PMC, 2022). Fewer than 1% of U.S. compounding pharmacies hold PCAB accreditation, since the program stays voluntary (Accreditation Commission for Health Care, 2026). The record is checkable in minutes.
What to know before you fill a prescription there
A pharmacy selling compounded medication without a prescription is operating outside the rules — so is one labeled "research use only" but marketed for personal use. Red flags: no named pharmacist-in-charge, no license-lookup match, and marketing built around a specific outcome, not the preparation.
The Halftime POV
We build around a state-licensed pharmacy relationship we can verify, not assume. We'd rather a member spend five minutes checking a license and inspection record than take quality on faith. The DQSA (Drug Quality and Security Act) created section 503B and set that standard in law.
Related reading:
- What PCAB accreditation actually is
- PCAB accreditation vs. USP <797>: what each one checks
- Section 503A: the regulatory history behind compounding
- Gray-market quality risk: what accreditation doesn't cover
FAQ
Q: How do I evaluate a compounding pharmacy before filling a prescription? A: Check six things: state licensure through your state board of pharmacy, whether it operates under section 503A or 503B, PCAB accreditation status, whether finished preparations are third-party tested with a certificate of analysis available, compliance with USP <797> or USP <795>, and its FDA inspection and warning-letter history.
Q: What is the difference between 503A and 503B? A: Section 503A pharmacies compound patient-specific prescriptions and are overseen mainly by state boards of pharmacy. Section 503B outsourcing facilities register with the FDA, make larger batches without a patient name attached, and are inspected under CGMP, current good manufacturing practice rules.
Q: Is PCAB accreditation required for a compounding pharmacy? A: No. PCAB, the Pharmacy Compounding Accreditation Board, is a voluntary third-party review. Its absence does not disqualify a pharmacy, but its presence is a useful, verifiable signal of process oversight.
Q: How do I know if a compounding pharmacy is licensed in my state? A: Use your state board of pharmacy's public license lookup, reachable through the NABP (National Association of Boards of Pharmacy) directory of state boards. A pharmacy must hold a license in your state, not only its home state.
Q: What red flags suggest a compounding pharmacy should be avoided? A: Selling without a prescription, "research use only" labeling on something meant for a person, no named pharmacist-in-charge, no match in a state license lookup, and marketing that promises a specific personal outcome instead of describing the preparation.
Disclaimer
This article is educational and is not medical advice. Compounded medications are not FDA-approved. Clinical outcomes depend on individual factors and require physician evaluation. Results vary. Halftime Health is launching soon — join the waitlist to get updates.
Get updates
Halftime Health is launching soon. We'll share what we learn along the way — the research, the regulations, the real-world trade-offs. Join the waitlist and we'll email you when we're live.
Sources
- FDC Act Provisions That Apply to Human Drug Compounding — FDA
- Inspection Classification Database — FDA (2026)
- Content Analysis of US FDA Warning Letters Issued to Compounding Pharmacies for CGMP Violations, 2017-2022 — PMC, National Library of Medicine
- General Chapter <797> — USP Compounding Standards
- General Chapter <795> — USP Compounding Standards
- PCAB Accreditation — Accreditation Commission for Health Care
Frequently asked questions
How do I evaluate a compounding pharmacy before filling a prescription?
Check six things: state licensure through your state board of pharmacy, whether it operates under section 503A or 503B, PCAB accreditation status, whether finished preparations are third-party tested with a certificate of analysis available, compliance with USP <797> or USP <795>, and its FDA inspection and warning-letter history.
What is the difference between 503A and 503B?
Section 503A pharmacies compound patient-specific prescriptions and are overseen mainly by state boards of pharmacy. Section 503B outsourcing facilities register with the FDA, make larger batches without a patient name attached, and are inspected under CGMP, current good manufacturing practice rules.
Is PCAB accreditation required for a compounding pharmacy?
No. PCAB, the Pharmacy Compounding Accreditation Board, is a voluntary third-party review. Its absence does not disqualify a pharmacy, but its presence is a useful, verifiable signal of process oversight.
How do I know if a compounding pharmacy is licensed in my state?
Use your state board of pharmacy's public license lookup, reachable through the NABP (National Association of Boards of Pharmacy) directory of state boards. A pharmacy must hold a license in your state, not only its home state.
What red flags suggest a compounding pharmacy should be avoided?
Selling without a prescription, 'research use only' labeling on something meant for a person, no named pharmacist-in-charge, no match in a state license lookup, and marketing that promises a specific personal outcome instead of describing the preparation.
Keep reading
A licensed physician can build a protocol from your own labs.
Membership from $69/mo, including your onboarding panel. Each protocol is its own monthly subscription.